NYSE: BAKBraskem Sa Stock
$8.14+0.02 (+0.25%)
Updated Nov 28, 2023
BAK Price
$8.14
Fair Value Price
N/A
Market Cap
$3.24B
52 Week Low
$6.26
52 Week High
$12.67
P/E
-48.17x
P/B
2.21x
P/S
0.2x
PEG
N/A
Dividend Yield
N/A
Revenue
$19.38B
Earnings
-$63.46M
Gross Margin
11.8%
Operating Margin
6.42%
Profit Margin
-0.3%
Debt to Equity
11.19
Operating Cash Flow
$3B
Beta
1.38
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
BAK Overview
Braskem SA is the largest petrochemical company in Latin America and the 8th largest resin producer worldwide. The company produces over 16 million tons of thermoplastic resins and other petrochemicals per year. Braskem also produces biopolymers from sugarcane-based ethanol. The company was founded in 2002 and is headquartered in São Paulo, Brazil.
Zen Score
–
Industry Average (32)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how BAK scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
BAK is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
BAK is poor value based on its book value relative to its share price (2.21x), compared to the US Chemicals industry average (1.69x)
P/B vs Industry Valuation
BAK is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 35 more BAK due diligence checks available for Premium users.
Be the first to know about important BAK news, forecast changes, insider trades & much more!
BAK News
Valuation
BAK price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-48.17x
Industry
17.54x
Market
32.56x
BAK price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
2.21x
Industry
1.69x
BAK is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation
BAK's financial health
Profit margin
Revenue
$18.2B
Net Income
-$63.5M
Profit Margin
-0.3%
BAK's Earnings (EBIT) of $1.24B... subscribe to Premium to read more.
Interest Coverage Financials
BAK's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$16.6B
Liabilities
$15.5B
Debt to equity
11.19
BAK's short-term assets ($6.92B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
BAK's long-term liabilities ($11.60B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
BAK's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
BAK's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$2.5B
Investing
-$935.2M
Financing
$42.6M
BAK's operating cash flow ($2.71B)... subscribe to Premium to read more.
Debt Coverage Financials
BAK vs Chemical Stocks
Braskem Sa Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.